A randomized Phase I pre-operative window trial of transdermal endoxifen in women planning mastectomy: Evaluation of dermal safety, intra-mammary drug distribution, and biologic effects.

Autor: Lee O; Department of Surgery, Northwestern University Feinberg School of Medicine, Chicago, IL, USA. Electronic address: o-lee@northwestern.edu., Bazzi LA; Department of Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA., Xu Y; Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, IL, USA., Pearson E; Department of Pathology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA., Wang M; Department of Surgery, Northwestern University Feinberg School of Medicine, Chicago, IL, USA., Hosseini O; Department of Surgery, Northwestern University Feinberg School of Medicine, Chicago, IL, USA., Akasha AM; Department of Surgery, Northwestern University Feinberg School of Medicine, Chicago, IL, USA., Choi JN; Department of Dermatology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA., Karlan S; Saul and Joyce Brandman Breast Center, Cedars-Sinai Medical Center, West Hollywood, CA, USA., Pilewskie M; Department of Surgery, University of Michigan, Ann Arbor, MI, USA., Kocherginsky M; Department of Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA., Benante K; Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, IL, USA., Helland T; Hormone Laboratory, Department of Medical Biochemistry and Pharmacology, Haukeland University Hospital, Bergen, Norway; Department of Clinical Science, University of Bergen, Bergen, Norway., Mellgren G; Hormone Laboratory, Department of Medical Biochemistry and Pharmacology, Haukeland University Hospital, Bergen, Norway; Department of Clinical Science, University of Bergen, Bergen, Norway., Dimond E; Division of Cancer Prevention, National Cancer Institute, Bethesda, MD, USA., Perloff M; Division of Cancer Prevention, National Cancer Institute, Bethesda, MD, USA., Heckman-Stoddard BM; Division of Cancer Prevention, National Cancer Institute, Bethesda, MD, USA., Khan SA; Department of Surgery, Northwestern University Feinberg School of Medicine, Chicago, IL, USA. Electronic address: s-khan2@northwestern.edu.

Publikováno v: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie [Biomed Pharmacother] 2024 Feb; Vol. 171, pp. 116105. Date of Electronic Publication: 2024 Jan 02.

Phase Ib trial of inhaled iloprost for the prevention of lung cancer with predictive and response biomarker assessment.

Autor: Miller YE; Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado, Aurora, CO, United States.; Pulmonary and Critical Care Section, RMR VAMC Rocky Mountain Regional Veteran Administration Medical Center, Aurora, CO, United States., Ghosh M; Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado, Aurora, CO, United States., Merrick DT; Department of Pathology, University of Colorado, Aurora, CO, United States., Kubala B; Cancer Center Clinical Trial Core, University of Colorado, Aurora, CO, United States., Szabo E; Division of Cancer Prevention, National Cancer Institute, Bethesda, MD, United States., Bengtson L; Division of Cancer Prevention, National Cancer Institute, Bethesda, MD, United States., Kocherginsky M; Department of Preventative Medicine, Northwestern University, Evanston, IL, United States., Helenowski IB; Department of Preventative Medicine, Northwestern University, Evanston, IL, United States., Benante K; Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Evanston, IL, United States., Schering T; Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Evanston, IL, United States., Kim J; Department of Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH, United States., Kim H; Department of Genetics and Genome Sciences, Case Western Reserve University, Cleveland, OH, United States., Ha D; Pulmonary and Critical Care Section, RMR VAMC Rocky Mountain Regional Veteran Administration Medical Center, Aurora, CO, United States., Bergan RC; Fred and Pamela Buffett Cancer Center, Division of Oncology & Hematology, Genitourinary Oncology, University of Nebraska, Evanston, IL, United States., Khan SA; Department of Surgery, Northwestern University, Omaha, NE, United States., Keith RL; Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado, Aurora, CO, United States.; Pulmonary and Critical Care Section, RMR VAMC Rocky Mountain Regional Veteran Administration Medical Center, Aurora, CO, United States.

Publikováno v: Frontiers in oncology [Front Oncol] 2023 Aug 30; Vol. 13, pp. 1204726. Date of Electronic Publication: 2023 Aug 30 (Print Publication: 2023).

A Randomized, Double-Blinded, Placebo-Controlled Trial of Simvastatin to Prevent Recurrent Pancreatitis.

Autor: Goodman MT, Lo SK, Yadav D, Wu BU, Jamil LH, Kwok KK, Papachristou GI, Afghani E, Choi-Kuaea Y, Waldron RT, Lombardi C, Jeon CY, Helenowski IB, Richmond E, Benante K, Habtezion A, Schering T, Khan SA, Rodriguez LM, Pandol SJ

Publikováno v: Pancreas [Pancreas] 2022 Jan 01; Vol. 51 (1), pp. e10-e12.

A Phase I Trial of Berberine in Chinese with Ulcerative Colitis.

Autor: Xu L; Department of Gastroenterology, Xijing Hospital, Fourth Military Medical University, Xi'an, China., Zhang Y; Department of Gastroenterology, Xijing Hospital, Fourth Military Medical University, Xi'an, China., Xue X; Department of Gastroenterology, Xijing Hospital, Fourth Military Medical University, Xi'an, China., Liu J; Department of Gastroenterology, Xijing Hospital, Fourth Military Medical University, Xi'an, China., Li ZS; Department of Pathology, Xijing Hospital, Fourth Military Medical University, Xi'an, China., Yang GY; Department of Pathology, Northwestern University, Chicago, Illinois., Song Y; Department of Pharmacology, Xijing Hospital, Fourth Military Medical University, Xi'an, China., Pan Y; Department of Gastroenterology, Xijing Hospital, Fourth Military Medical University, Xi'an, China., Ma Y; Department of Clinical Laboratory Medicine, Xijing Hospital, Fourth Military Medical University, Xi'an, China., Hu S; Department of Gastroenterology, Xijing Hospital, Fourth Military Medical University, Xi'an, China., Wen A; Department of Pharmacology, Xijing Hospital, Fourth Military Medical University, Xi'an, China., Jia Y; Department of Pharmacology, Xijing Hospital, Fourth Military Medical University, Xi'an, China., Rodriguez LM; Division of Cancer Prevention, NCI, Bethesda, Maryland.; Walter Reed Military Medical Center, Department of Surgery, Bethesda, Maryland., Tull MB; Robert H. Lurie Cancer Center, Northwestern University, Chicago, Illinois., Benante K; Robert H. Lurie Cancer Center, Northwestern University, Chicago, Illinois., Khan SA; Department of Surgery and Northwestern University, Chicago, Illinois., Cao Y; Department of Gastroenterology, Xijing Hospital, Fourth Military Medical University, Xi'an, China., Jovanovic B; Department of Preventive Medicine, Northwestern University, Chicago, Illinois., Richmond E; Division of Cancer Prevention, NCI, Bethesda, Maryland., Umar A; Division of Cancer Prevention, NCI, Bethesda, Maryland., Bergan R; Division of Hematology and Medical Oncology, Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon. kaicwu@fmmu.edu.cn bergan@ohsu.edu., Wu K; Department of Gastroenterology, Xijing Hospital, Fourth Military Medical University, Xi'an, China. kaicwu@fmmu.edu.cn bergan@ohsu.edu.

Publikováno v: Cancer prevention research (Philadelphia, Pa.) [Cancer Prev Res (Phila)] 2020 Jan; Vol. 13 (1), pp. 117-126. Date of Electronic Publication: 2019 Oct 16.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.